13G Filing: Empery Asset Management, LP and Eyegate Pharmaceuticals Inc (EYEG)

Page 8 of 9 – SEC Filing

SIGNATURES

After reasonable inquiry and to the best
of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

DATED: June 14, 2017

EMPERY ASSET MANAGEMENT, LP
By: EMPERY AM GP, LLC, its General Partner
By: /s/ Ryan M. Lane                                      
Name:  Ryan M. Lane
Title:  Managing Member
/s/ Ryan M. Lane                                            
Ryan M. Lane
/s/ Martin D. Hoe                                            
Martin D. Hoe

 

Follow Kiora Pharmaceuticals Inc (NASDAQ:KPRX)